Scott Conard

1.1k total citations
30 papers, 793 citations indexed

About

Scott Conard is a scholar working on General Health Professions, Surgery and Economics and Econometrics. According to data from OpenAlex, Scott Conard has authored 30 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in General Health Professions, 8 papers in Surgery and 7 papers in Economics and Econometrics. Recurrent topics in Scott Conard's work include Lipoproteins and Cardiovascular Health (8 papers), Healthcare professionals’ stress and burnout (7 papers) and Pharmaceutical Economics and Policy (5 papers). Scott Conard is often cited by papers focused on Lipoproteins and Cardiovascular Health (8 papers), Healthcare professionals’ stress and burnout (7 papers) and Pharmaceutical Economics and Policy (5 papers). Scott Conard collaborates with scholars based in United States and Canada. Scott Conard's co-authors include David V. Sheehan, Patrick H. Hughes, DeWitt C. Baldwin, Carla L. Storr, Patrick Dunn, Harold Bays, Lawrence A. Leiter, Andrew M. Tershakovec, Steven Bird and Joanne E. Tomassini and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal of Psychiatry and The American Journal of Cardiology.

In The Last Decade

Scott Conard

30 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Conard United States	13	358	188	180	114	82	30	793
Chester Pabiniak United States	16	228 0.6×	117 0.6×	194 1.1×	155 1.4×	28 0.3×	23	1.5k
Jing Liao China	17	266 0.7×	141 0.8×	110 0.6×	46 0.4×	15 0.2×	104	1.1k
Paula Chatterjee United States	17	461 1.3×	102 0.5×	177 1.0×	306 2.7×	16 0.2×	54	1.2k
John C. Scott United States	15	301 0.8×	126 0.7×	103 0.6×	110 1.0×	10 0.1×	27	907
Linn Getz Norway	19	436 1.2×	83 0.4×	369 2.0×	169 1.5×	10 0.1×	70	1.3k
Mary Bond United States	16	141 0.4×	51 0.3×	136 0.8×	40 0.4×	21 0.3×	42	769
Elizabeth Rogers United States	15	128 0.4×	322 1.7×	320 1.8×	32 0.3×	29 0.4×	33	953
Vincent G. Iannacchione United States	13	240 0.7×	81 0.4×	69 0.4×	117 1.0×	21 0.3×	18	921
Johanne Collin Canada	16	236 0.7×	91 0.5×	65 0.4×	188 1.6×	12 0.1×	62	865
Elisabeth Kenne Sarenmalm Sweden	18	291 0.8×	90 0.5×	219 1.2×	24 0.2×	22 0.3×	39	1.0k

Countries citing papers authored by Scott Conard

Since Specialization

Citations

This map shows the geographic impact of Scott Conard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Conard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Conard more than expected).

Fields of papers citing papers by Scott Conard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Conard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Conard. The network helps show where Scott Conard may publish in the future.

Co-authorship network of co-authors of Scott Conard

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Conard. A scholar is included among the top collaborators of Scott Conard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Conard. Scott Conard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Volgman, Annabelle Santos, Patrick Dunn, Scott Conard, et al.. (2019). Risk Factors for Symptomatic Atrial Fibrillation-Analysis of an Outpatient Database. Journal of Atrial Fibrillation. 12(1). 2141–2141. 5 indexed citations

Conard, Scott. (2019). Best practices in digital health literacy. International Journal of Cardiology. 292. 277–279. 100 indexed citations

Dunn, Patrick & Scott Conard. (2018). Improving health literacy in patients with chronic conditions: A call to action. International Journal of Cardiology. 273. 249–251. 70 indexed citations

Dunn, Patrick, et al.. (2017). Playing the Game of Health: Best Practices for Health Optimization Program in a Worksite Setting, with Case Study of a Real World Example. 2(1). 41–41. 1 indexed citations

Bloom, Lisa, et al.. (2013). A call for physician leadership at all levels.. PubMed. 39(2). 24–6, 28, 30. 2 indexed citations

Conard, Scott, et al.. (2011). The Game of Health^©: An innovative lifestyle change program implemented in a family practice. Journal of the American Academy of Nurse Practitioners. 23(6). 289–297. 7 indexed citations

Bays, Harold, Scott Conard, Lawrence A. Leiter, et al.. (2010). Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading?. Lipids in Health and Disease. 9(1). 136–136. 19 indexed citations

Bays, Harold, Scott Conard, Lawrence A. Leiter, et al.. (2010). Influence of age, gender, and race on the efficacy of adding ezetimibe to atorvastatin vs. atorvastatin up-titration in patients at moderately high or high risk for coronary heart disease. International Journal of Cardiology. 153(2). 141–147. 9 indexed citations

Bays, Harold, Scott Conard, Lawrence A. Leiter, et al.. (2010). ARE POST-TREATMENT LOW DENSITY LIPOPROTEIN SUBCLASS PATTERN ANALYSES POTENTIALLY MISLEADING?. Journal of the American College of Cardiology. 55(10). A53.E499–A53.E499. 1 indexed citations

10.

Leiter, Lawrence A., Harold Bays, Scott Conard, et al.. (2010). Attainment of Canadian and European guidelines’ lipid targets with atorvastatin plus ezetimibe vs. doubling the dose of atorvastatin. International Journal of Clinical Practice. 64(13). 1765–1772. 4 indexed citations

11.

Conard, Scott, Harold Bays, Lawrence A. Leiter, et al.. (2009). Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither. Diabetes Obesity and Metabolism. 12(3). 210–218. 29 indexed citations

12.

Conard, Scott, Harold Bays, Lawrence A. Leiter, et al.. (2008). Efficacy and Safety of Ezetimibe Added on to Atorvastatin (20 mg) Versus Uptitration of Atorvastatin (to 40 mg) in Hypercholesterolemic Patients at Moderately High Risk for Coronary Heart Disease††Conflicts of interest: Dr. Conard served as a consultant and advisor for Merck & Company and Merck/Schering-Plough. Dr. Bays received research grants from Amylin, San Diego, California, Amgen, Thousand Oaks, California, J&J, Langhorne, Pennsylvania, Aegerion, Bridgewater, New Jersey, Abbott, Chicago, Illinois, Arena Pharmaceuticals, San Diego, California, GlaxoSmithKline (Glaxo), London, UK, Hoffmann LaRoche, Nutley, New Jersey, Merck, Whitehouse Station, New Jersey, MSP, Kenilworth, New Jersey, Metabolex, San Jose, California, Schering-Plough, Kenilworth, New Jersey, Orexigen, San Diego, California, Reliant, Liberty Corner, New Jersey, Sciele, Atlanta, Georgia, Takeda, Osaka, Japan, TAP, Lake Forest, Illinois, and Vivus, Mountain View, California; received speakers' honoraria from Abbott, Daiichi Sankyo, Tokyo, Japan, GlaxoSmithKline, Reliant, Merck & Company, Merck/Schering-Plough, and Schering-Plough; received honoraria from Abbott, AstraZeneca, London, UK (Wilmington, Delaware, US Headquarters), Daiichi Sankyo, GlaxoSmithKline, Reliant, Merck & Company, Merck/Schering-Plough, and Schering-Plough; and served as a consultant and advisor for Abbott, GlaxoSmithKline, Metabolex, San Jose, California, Reliant, Takeda, AstraZeneca, and Essentialis, Carlsbad, California. Dr. Leiter received grants and speakers' honoraria from and served as a consultant and advisor for AstraZeneca, Merck & Company, Merck/Schering-Plough, and Pfizer, New York, New York. Mr. Bird, Mr. Rubino, and Drs. Lowe, Tomassini, and Tershakovec are employees of Merck & Company and may own stock and/or hold stock options in the company.. The American Journal of Cardiology. 102(11). 1489–1494. 62 indexed citations

13.

Leiter, Lawrence A., Harold Bays, Scott Conard, et al.. (2008). Efficacy and Safety of Ezetimibe Added on to Atorvastatin (40 mg) Compared With Uptitration of Atorvastatin (to 80 mg) in Hypercholesterolemic Patients at High Risk of Coronary Heart Disease. The American Journal of Cardiology. 102(11). 1495–1501. 71 indexed citations

14.

Hughes, Patrick H., DeWitt C. Baldwin, David V. Sheehan, Scott Conard, & Carla L. Storr. (1992). Resident physician substance use, by specialty. American Journal of Psychiatry. 149(10). 1348–1354. 98 indexed citations

15.

Jex, Steve M., Patrick H. Hughes, Carla L. Storr, et al.. (1992). Relations among Stressors, Strains, and Substance Use among Resident Physicians. International Journal of the Addictions. 27(8). 979–994. 20 indexed citations

16.

Conard, Scott, et al.. (1992). Patterns of substance use in the medical profession.. PubMed. 41(4). 311–4. 15 indexed citations

17.

Jex, Steve M., DeWitt C. Baldwin, Patrick H. Hughes, et al.. (1991). Behavioral Consequences of Job-Related Stress among Resident Physicians: The Mediating Role of Psychological Strain. Psychological Reports. 69(1). 339–349. 25 indexed citations

18.

Hughes, Patrick H., et al.. (1991). Resident Physician Substance Use in the United States. Survey of Anesthesiology. XXXV(6). 363–363. 1 indexed citations

19.

Baldwin, DeWitt C., Patrick H. Hughes, Scott Conard, Carla L. Storr, & David V. Sheehan. (1991). Substance use among senior medical students. A survey of 23 medical schools.. PubMed. 265(16). 2074–8. 143 indexed citations

20.

Conard, Scott, Patrick H. Hughes, DeWitt C. Baldwin, Karl Achenbach, & David V. Sheehan. (1988). Substance use by fourth-year students at 13 U.S. medical schools. Academic Medicine. 63(10). 747–58. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact